Showing 5,041 - 5,060 results of 60,129 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (teer decrease)) ))', query time: 0.79s Refine Results
  1. 5041
  2. 5042
  3. 5043
  4. 5044

    Representative experimental samples. by Weisheng Zhao (3746023)

    Published 2025
    “…Based on the mechanical test results, reducing humidity can decrease the loss of uniaxial compressive strength (UCS) caused by moisture absorption from approximately 50% to 15.48%. …”
  5. 5045

    Mechanical testing apparatus and samples. by Weisheng Zhao (3746023)

    Published 2025
    “…Based on the mechanical test results, reducing humidity can decrease the loss of uniaxial compressive strength (UCS) caused by moisture absorption from approximately 50% to 15.48%. …”
  6. 5046

    Relationship between UCS, E, and water content. by Weisheng Zhao (3746023)

    Published 2025
    “…Based on the mechanical test results, reducing humidity can decrease the loss of uniaxial compressive strength (UCS) caused by moisture absorption from approximately 50% to 15.48%. …”
  7. 5047

    Hygroscopic experimental device. by Weisheng Zhao (3746023)

    Published 2025
    “…Based on the mechanical test results, reducing humidity can decrease the loss of uniaxial compressive strength (UCS) caused by moisture absorption from approximately 50% to 15.48%. …”
  8. 5048

    Data_Sheet_1_Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder.PDF by Valeria Ruggiero (631884)

    Published 2023
    “…By evaluating both cap-dependent and cap-independent translation initiation, we suggest the presence of an IRES supporting the translation of CDKL5 mRNA and propose a pathogenic effect of the C>T -189 SNP in decreasing the translation of the downstream protein.…”
  9. 5049

    Data_Sheet_2_Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder.pdf by Valeria Ruggiero (631884)

    Published 2023
    “…By evaluating both cap-dependent and cap-independent translation initiation, we suggest the presence of an IRES supporting the translation of CDKL5 mRNA and propose a pathogenic effect of the C>T -189 SNP in decreasing the translation of the downstream protein.…”
  10. 5050

    Flipping the Switch: Reverse-Demand Voltage-Sensitive Fluorophores by Jack T. McCann (13047830)

    Published 2022
    “…Our group has been developing voltage-sensitive fluorophores (VF dyes) that respond to changes in biological membrane potential (<i>V</i><sub>m</sub>). We hypothesize that the mechanism of voltage sensitivity arises from acceptor PeT (a-PeT) from an electron-rich aniline-containing molecular wire into the excited-state fluorophore, resulting in decreased fluorescence at negative <i>V</i><sub>m</sub>. …”
  11. 5051

    Genes in extracellular clusters E1-5. by Gareth A. Cromie (17118013)

    Published 2024
    “…We demonstrate that in the F13 genetic background deletions of transcription factors can either increase <i>(dig1</i>D, <i>sfl1</i>D) or decrease <i>(tec1</i>D) the degree of colony structure. …”
  12. 5052

    Supplementary Material for: Case fatality rates of subarachnoid hemorrhage are decreasing with substantial between-country variation: a systematic review of population-based studie... by Mahlamäki K. (13774423)

    Published 2022
    “…Since these same risk factors are linked to SAH mortality, the case fatality rate (CFR) of SAH has potentially also decreased during recent decades. Thus, we conducted a systematic review to address SAH CFR changes over the last 40 years. …”
  13. 5053
  14. 5054

    table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  15. 5055

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  16. 5056

    image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  17. 5057

    table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  18. 5058

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  19. 5059

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  20. 5060